After months of steady decline inside a falling channel, ICICI Prudential Life is showing early signs of reversal. The stock has recently broken out of its channel with a strong bullish weekly candle, closing at ₹571.70 with a +4.5% gain. Volume is picking up, and RSI is curling up above 40 with a bullish divergence—indicating momentum is building. Price is now near a key resistance zone (~₹590–₹610); a clean breakout here could confirm trend reversal.
📊 Financial Snapshot
Net Premium Income: ₹10,169 Cr vs ₹9,465 Cr ⬆️
PAT: ₹226 Cr vs ₹221 Cr (flat YoY)
VNB Margin: Healthy at 26.7%
Embedded Value: ₹47,020 Cr
Solvency Ratio: Strong at 211%
AUM: ₹2.88 Lakh Cr
💡 Why Consider Buying?
Reversal setup after long correction
Attractive risk-reward near base
Steady premium growth, strong solvency
Long-term growth play on India’s underpenetrated life insurance sector
🚫 Risks / Why to Wait:
Resistance at ₹590–₹610 still intact
PAT growth has been flat
Sector sentiment can be sensitive to interest rate trends
🎯 Trade Setup:
Buy Zone: ₹565–575
Target 1: ₹610
Target 2: ₹660
Stop Loss: ₹540
for educational purposes only
📊 Financial Snapshot
Net Premium Income: ₹10,169 Cr vs ₹9,465 Cr ⬆️
PAT: ₹226 Cr vs ₹221 Cr (flat YoY)
VNB Margin: Healthy at 26.7%
Embedded Value: ₹47,020 Cr
Solvency Ratio: Strong at 211%
AUM: ₹2.88 Lakh Cr
💡 Why Consider Buying?
Reversal setup after long correction
Attractive risk-reward near base
Steady premium growth, strong solvency
Long-term growth play on India’s underpenetrated life insurance sector
🚫 Risks / Why to Wait:
Resistance at ₹590–₹610 still intact
PAT growth has been flat
Sector sentiment can be sensitive to interest rate trends
🎯 Trade Setup:
Buy Zone: ₹565–575
Target 1: ₹610
Target 2: ₹660
Stop Loss: ₹540
for educational purposes only
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.